Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Johnson & Johnson (JNJ)

Healthcare Drug Manufacturers - General
256.40 $
+0.2% vs. previous close
Closing price · As of: 31. Jul 2026

Johnson & Johnson (JNJ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 201,060 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet JNJ
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
166,061 167,558 171,966 181,088 178,287 180,104 193,671 193,389 192,816 199,210 200,894 201,060
53,703 53,495 57,002 57,817 53,249 55,893 71,551 54,498 54,611 55,624 59,173 59,774
19,728 21,859 25,473 24,878 19,980 24,105 38,474 18,577 18,231 19,709 21,688 20,422
23,511 22,927 26,218 25,475 20,297 24,522 38,781 18,880 18,562 20,102 22,051 20,758
14,798 19,387 14,946 15,794 16,174 18,927 16,020 17,846 17,611 17,178 17,721 19,046
11,198 11,181 11,383 12,169 12,603 12,444 12,659 13,412 14,146 14,191 14,583 15,144
18,821 20,479 21,618 20,871 21,949 22,338 24,469
36,124 36,558 36,616 44,250 44,799 44,200 44,468 48,117 48,048 48,772 48,558 48,479
35,021 34,175 34,286 39,725 39,490 37,618 36,755 49,835 48,737 50,403 49,061 48,229
94,833 98,784 101,946 109,550 108,129 108,614 115,562 114,916 113,539 117,666 119,708 116,090
44,370 46,282 48,725 53,933 51,759 50,321 56,903 54,180 50,869 54,126 57,716 54,895
3,870 3,451 8,550 9,855 4,462 5,983 13,897 11,526 6,387 8,495 17,460 11,692
8,355 9,632 8,174 8,848 8,954 10,311 9,545 9,464 9,625 11,991 10,460 9,223
26,051 25,881 25,082 31,636 31,289 30,651 38,355 39,235 39,408 39,438 37,527 37,344
71,228 68,774 70,020 71,538 70,158 71,490 78,109 78,473 79,277 81,544 81,186 84,971
152,536 153,843 153,378 155,360 155,179 155,791 162,635 165,371 167,281 168,978 169,161 171,665
2,550 2,431 2,430 2,422 2,428 2,427 2,424 2,419 2,429 2,439 2,445 2,440

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?